Landstrasser Guertel 3 Vienna, 1030 AustriaA creative agency, an internet agency, a pr agency… or straightaway a full-service agency? Definitions are blurring and to be honest – they do not matter anymore. What really matters are unique concepts which guarantee visibility for brands and topics and are put into practice state-of-the-art. Websites, long-term pr guidance, social media campaigns, content management, user experience, SEO, and analytics: all of those services require very specific and versatile know-how – and that’s exactly what asoluto is standing for.

7 Petőfi Sándor utca Dunaremete, 9235 HungaryThe Agrofil-SZMI Ltd. 200 0-started its activity in two-person family business. In 2005, 5 people, 12 people in 2010, and today the number of employees is 28 people. Our headquarters is located in the inter-island Pushkin. In 2007, a South Plains telepho expanding our llyel where the work currently carried out by seven colleagues. Professional request sense proves ültségünket that our employees are 21 people has a degree in agricultural engineering, specialist plant and 11 people also. Dynamic development of our growth reflects not only the number of staff. The number of test plots grown nearly tenfold in 10 years; while in 2002, 350 parcels per year were carried out experimental activities, while in 2011 the figure was more than 31,000. Especially the trust and the continuous professional development of our technical due to this large-scale growth. A detailed description of asset base in located.

Donau-City-Straße 1 Vienna, 1220 Austria AIT stands as Austria's premier applied non-university research institute. Within AIT, the Molecular Diagnostics unit specializes in cutting-edge non- and minimally invasive diagnostics. Our contract research services encompass transcriptomics, epigenetics, proteomics and immunomics. Expertise spans biomarker discovery, assay design, validation, and bioinformatics. We excel in tailored analysis, multiplexed testing with minimal clinical specimens, established workflows, and custom assay development for clients’ platforms. Moreover, we provide human in vitro models of biological barriers (e.g., blood-brain barrier) to study drugs, drug delivery systems, toxins, species differences and diseases (e.g. neurodevelopmental, stroke, TBI, Alzheimer disease, etc.). On the diagnostic hardware side, we develop innovative biosensors and point-of-care tools and provide our expertise and solutions for contract research and development.

Vienna, Vienna Austria AIT stands as Austria's premier applied non-university research institute. Within AIT, the Molecular Diagnostics unit specializes in cutting-edge non- and minimally invasive diagnostics. Our contract research services encompass transcriptomics, epigenetics, proteomics and immunomics. Expertise spans biomarker discovery, assay design, validation, and bioinformatics. We excel in tailored analysis, multiplexed testing with minimal clinical specimens, established workflows, and custom assay development for clients’ platforms. Moreover, we provide human in vitro models of biological barriers (e.g., blood-brain barrier) to study drugs, drug delivery systems, toxins, species differences and diseases (e.g. neurodevelopmental, stroke, TBI, Alzheimer disease, etc.). On the diagnostic hardware side, we develop innovative biosensors and point-of-care tools and provide our expertise and solutions for contract research and development.

Leberstrasse 20/2, Vienna, 1110 AustriaOur Mission. … is to provide and to develop novel highly-innovative laboratory tests to identify (rare) diseases on an early stage to give patients the chance for a personalized therapeutical treatment with best possible outcome. Finding the correct diagnosis particularly for children and patients with rare disorders can take months or even years while disease has begun to progress… We commit to change this situation to make better laboratory tests accessible. Personalized Diagnostics for Better Health! We are pioneering new ways to provide better laboratory services to you!

20 Leberstraße, Wien, Wien 1110, ATOur Mission. … is to provide and to develop novel highly-innovative laboratory tests to identify (rare) diseases on an early stage to give patients the chance for a personalized therapeutical treatment with best possible outcome. Finding the correct diagnosis particularly for children and patients with rare disorders can take months or even years while disease has begun to progress… We commit to change this situation to make better laboratory tests accessible. Personalized Diagnostics for Better Health! We are pioneering new ways to provide better laboratory services to you!

Galvaniho 7/D 821 04 Bratislava, SlovakiaArgint International provides clinical operations, regulatory services, and project management, primarily for eastern european countries.

2 Helmut-Qualtinger-Gasse Wien, Wien, 1030 AustriaArsanis is a biotechnology company dedicated to the development of human antibody based therapeutics against severe infectious diseases.

Donau City Strasse 6 1220 Wien, AustriaAssign Group is a fully integrated biotech and pharmaceutical service provider.

Vienna, Vienna AustriaAssign Group is a fully integrated biotech and pharmaceutical service provider.

Rohrau, Lower Austria, 2471 AustriaOur work reaches back to 1986. As part of the research facilities of the previous company Stauffer Chemicals, work originally focused on the development of maize herbicides. Our guiding principle of highest quality was established, remaining unchanged to the present day. An essential criterion generated at our trial sites for the establishment of our test facility in these days were representative soil and climate conditions for Central and Eastern Europe complemented by excellent infrastructure. Today, top quality and flexibility form the basis of our international success.

Brehmstraße 14A Vienna, 1110 AustriaAttoquant Diagnostics provides LC-MS/MS based peptide quantification services at premium quality. We are specialized in the biochemical characterization of peptide hormone cascades with a major focus on the Renin-Angiotensin-Aldosterone-System. In addition to the quantification of different functionally related angiotensin metabolite panels (RAS-FingerprintTM), we offer highly sensitive activity assays for proteolytic enzymes that are based on natural peptide substrates. We also support you in bio-analytical planning, sample measurement and data interpretation. Attoquant Diagnostics provides MORE THAN JUST DATA! Attoquant Diagnostics GmbH is committed to ensuring the highest quality and reliability in all our analytical processes and to working in accordance with the guideline ‘EMA Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples’. Our company is also ISO 9001:2015 certified, highlighting our commitment to upholding the highest quality standards. In addition, we adhere to the current GCP (Good Clinical Practice) standards to ensure that all clinical trials and research projects meet the highest ethical and scientific requirements.

Austrian Research Centers GmbH - ARC 2444 Seibersdorf, AustriaAustrian Research Centers offers preclinical services, biomarker research, drug discovery support, regulatory consulting, and toxicology.

Campus Vienna Biocenter 2 Vienna 1030 Vienna AustriaBender MedSystems offers assay development, custom antibodies, in vitro diagnostics, and ELISAs.

11 Muthgasse Stiege 2 Vienna, Vienna, 1190 Austriabespark*bio is a Vienna-based biotech specializing in hands-on CMC and process development for viral vectors, biologics, and ATMPs. We support therapy developers from preclinical through late clinical stages. From designing processes from scratch and de-risking clinical entry, to troubleshooting bottlenecks, optimizing yields, and building scale-down models for process characterization. With our in-house labs, and the use of data modeling and machine learning, we accelerate CMC timelines, reduce lab workload, and help teams move more confidently toward GMP-readiness and commercialization. We also collaborate with technology providers and raw material suppliers, using established model systems to validate performance, generate benchmark data and explore new applications.

2 Helmut-Qualtinger-Gasse Wien, Wien, 1030 Austriabiolution is an international scientific communications and consulting company at the Vienna BioCenter in Neu Marx specializing in the life sciences sector. While we work within a large network of collaborators with complementary expertise, our core services are performed exclusively by our highly experienced and well-trained full-time staff. In our experience this ensures our services not only a consistently high level of quality, but also allows the effective delegation of tasks to the appropriate team member. Our experienced team of life scientists from a wide variety of scientific backgrounds is complemented by a professional media design team. Based on this multidisciplinary expertise and more than a decade of science communication experience biolution has built a state-of the-art 3 D visualization pipeline to generate scientifically accurate 3D models for instructive visualizations and videos. Our services in brief: 3D VISUALIZATION (still & animated, Videos) Educational | teaching | marketing | information | broadcasting | documentary | fundraising | public relations | media relations | social media COMMUNICATION Corporate design | Web- & graphic design | Print material |Social media | Video recording | Text editing CONSULTING EU funded cooperation in H2020 | ERC | FET | SME calls | Marie Skłodowska-Curie | Eurostars | EMBO fellowship | FWF | WWTF | LBG Institutes PROJECT MANAGEMENT Communication | Project controlling | Legal/financial/administrative support | Corrective measures | Meetings organisation & moderation EVENTS Strategy & concept development | Advice & support with presentations | Moderation | Public funding and sponsoring | Event marketing | Public relations inquiries | Technical set up & implementation

Vienna Competence Center Lazarettgasse 19 1090 Vienna AustriaBiomay offers recombinant proteins, plasmid DNA, and manufacturing services.

Campus Vienna Biocenter II Viehmarktgasse 2A Vienna, 1030 AustriaCritical Raw Materials and Services for Life Science and Diagnostics form R&D to GMP. Working across modalities, Biosynth provides a comprehensive set of problem-solving services and high quality products to help customers develop new therapies and diagnostics.   Biosynth Life Sciences provides expert services in small molecule manufacturing, bioconjugate and advanced polymer manufacture alongside complex peptide discovery and supply. These services pair with product specialties for high quality ongoing supply of bioprocess reagents and critical materials for the oligonucleotide supply chain.     Biosynth Diagnostics provides the leading diagnostics companies with critical materials including antigens and antibodies, innovative small molecule substrates and serum and plasma. This is complemented by an expanding collection of readily available products and custom projects to create recombinant proteins and enzymes, and complex peptides to replace proteins across assays. Key Capabilities and Expertise Biosynth is built around a specialist cross modality offering, delivering a comprehensive range of products and services. That’s why we offer a high-touch, expert-led partnership designed to move your science forward—faster. With decades of hands-on experience across modalities, our team becomes an extension of yours. We don’t just provide services—we bring strategic insight, scientific rigor, and operational agility to every stage of your pipeline. From practical to pioneering, we help you navigate complexity, reduce risk, and accelerate timelines—so that life-changing therapies and diagnostics can help patients sooner. Biosynth History Biosynth was founded in 1966, and has grown to a global products and services business. Biosynth merged with Carbosynth in 2019 to form Biosynth Carbosynth, creating a world leader in carbohydrates, nucleosides and enzyme substrates. In 2022 the company returned to the Biosynth brand, and embarked on a period of expansion and acquisition. The Biosynth Group acquired a number of companies from then on, including vivitide, Pepscan, Aalto Bio Reagents, EUCODIS Bioscience, Fitzgerald Industries International, Cambridge Research Biochemicals (CRB), celares, Pepceuticals, and VIO Chemicals. For more information please visit our website: https://www.biosynth.com/

Nobelova 34 Bratislava , Bratislava , 836 05 SlovakiaCritical Raw Materials and Services for Life Science and Diagnostics form R&D to GMP. Working across modalities, Biosynth provides a comprehensive set of problem-solving services and high quality products to help customers develop new therapies and diagnostics.   Biosynth Life Sciences provides expert services in small molecule manufacturing, bioconjugate and advanced polymer manufacture alongside complex peptide discovery and supply. These services pair with product specialties for high quality ongoing supply of bioprocess reagents and critical materials for the oligonucleotide supply chain.     Biosynth Diagnostics provides the leading diagnostics companies with critical materials including antigens and antibodies, innovative small molecule substrates and serum and plasma. This is complemented by an expanding collection of readily available products and custom projects to create recombinant proteins and enzymes, and complex peptides to replace proteins across assays. Key Capabilities and Expertise Biosynth is built around a specialist cross modality offering, delivering a comprehensive range of products and services. That’s why we offer a high-touch, expert-led partnership designed to move your science forward—faster. With decades of hands-on experience across modalities, our team becomes an extension of yours. We don’t just provide services—we bring strategic insight, scientific rigor, and operational agility to every stage of your pipeline. From practical to pioneering, we help you navigate complexity, reduce risk, and accelerate timelines—so that life-changing therapies and diagnostics can help patients sooner. Biosynth History Biosynth was founded in 1966, and has grown to a global products and services business. Biosynth merged with Carbosynth in 2019 to form Biosynth Carbosynth, creating a world leader in carbohydrates, nucleosides and enzyme substrates. In 2022 the company returned to the Biosynth brand, and embarked on a period of expansion and acquisition. The Biosynth Group acquired a number of companies from then on, including vivitide, Pepscan, Aalto Bio Reagents, EUCODIS Bioscience, Fitzgerald Industries International, Cambridge Research Biochemicals (CRB), celares, Pepceuticals, and VIO Chemicals. For more information please visit our website: https://www.biosynth.com/

P.O. Box 39, A-1150 Vienna, AustriaBiotechnology Consulting is a drug development and regulatory affairs management consultancy.

Dr.-Bruno-Klein-Strasse 2 A-3423 Woerdern, AustriaBiovest Consulting GmbH is an Austrian based life science and drug development consulting company established in 2002. Biovest primarily focusses on designing and managing rabbit monoclonal antibody development projects and acts as general contractor for its clients in pharmaceutical and biotech R&D departments. Biovest 's services are engaged for the scientific design and logistical management of challenging projects by a select group of clients.

Dr.-Bruno-Klein-Strasse 2 Woerdern, 3423 AustriaBiovest Consulting GmbH is an Austrian based life science and drug development consulting company established in 2002. Biovest primarily focusses on designing and managing rabbit monoclonal antibody development projects and acts as general contractor for its clients in pharmaceutical and biotech R&D departments. Biovest 's services are engaged for the scientific design and logistical management of challenging projects by a select group of clients.

Gonzagagasse 16/16, A 1010 Wien, AustriaChiesi farmaceutici offers drug development, drug discovery, and clinical trials.

Sulekova 14 811 06 Bratislava- Slovak RepublicChiesi farmaceutici offers drug development, drug discovery, and clinical trials.

Vienna, AustriaClinical Investigation Support provides clinical support with a focus on quality assurance.

Hauptstraße 5 Maria Enzersdorf, Vienna, 2344 AustriaEstablishment 1994 Founding of CoaChrom Diagnostica GmbH with company headquarters in Vienna, Austria. Company object Development, production and distribution of innovative and high quality reagents for haemostasis diagnostics. Strategic orientation It is our mission to be the most competent, progressive, reliable and not least the friendliest partner in the field of coagulation & fibrinolysis for our customers. For both scientific and practice-oriented questions, we must be able to offer information at any time in the way that you expect from a knowledge-oriented and dynamic company.

Alserstrasse 23/30 Vienna, Vienna, 1080 AustriaIn-silico based support for pharma to find new therapeutic options for a given indication and discover new indications for a given drug. Delta4 is an Austrian AI Drug Discovery TechBio Company that focuses on discovering undetected relationships between drugs with a known safety profile and diseases to identify new indications. Delta4 utilizes Hyper-C (standing for Hyper Connectivity), a platform housing an enormous collection of algorithmic intelligence. It is operated by a team of highly skilled computational biologists that carefully analyze the data to produce unique insights and opportunities. The platform feeds on big data and uses its algorithms and data integration to build molecular models which go through an iterative refinement process, matching them to diseases. This sophisticated process utilizes thousands of pre-computed models and effectively matches compounds to diseases for more efficient biological testing and clinical trials. What we can do for you: • find new indications for your existing drug • find new drugs in a given indication • identify and rank disease-modifying drug targets • propose prognostic and predictive protein biomarkers • provide specific background info on a drug effect/side effect • generate a strong MoA-hypothesis Several big names in the pharma space (e. g. Top-20 Pharma Company Germany, Top-20 Pharma Company Scandinavia, etc.) have already put our high tech platform (Hyper-C) to the test - with the highest satisfaction! You can view our publications here: https://delta4.ai/publications/

Muthgasse 11/2 1st floor Vienna, 1190 AustriaenGenes Biotech is an Austrian biotechnology company specialized in high-performance microbial production of recombinant proteins and plasmid DNA. Using its proprietary enGenes-eXpress technology and advanced secretion platforms, enGenes delivers growth-decoupled expression, high yields, and improved genetic stability across a wide variety of biomolecules. We offer end-to-end services ranging from strain engineering, plasmid construction, and antibiotic-marker-free/minicircle pDNA production to scalable batch, fed-batch, and continuous bioprocess development in controlled multibioreactor systems. This enables rapid feasibility studies, efficient scale-up, and reliable material generation for biopharma, diagnostics, and industrial biotechnology applications.

Brehmstarße 14A Vienna, AT-1110 AustriaFAST. We produce and analyse DNA & RNA. Eurofins Genomics is part of the Eurofins Group, with facilities in Europe, the USA and Asia. We are an internationally leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services. COMPLETE. We support you from research to application. With our assistance, you will master any challenge along your value chain. We combine outstanding expertise with state-of-the-art instruments, methods and technologies. We support standard and challenging research projects, as well as complex strategies for large interdisciplinary companies. RELIABLE. We work with academics, pharma, food, diagnostics, agriculture and biotechnology. Our highly automated and lean-optimised lab processes allow us to deliver highly-reliable results. This is documented by the ISO 17025 and ISO 13485 accreditation, as well as the GLP, GCP and cGMP certifications. Reach for the stars. We are glad to assist you!

Shuttleworthstraße 19, A-1210 ViennaFavorgen Biotech Corporation supplies DNA/RNA extraction kits and consumables.

7 Schwarzenbergplatz Wien, Wien, 1030 AustriaF-star is a biopharmaceutical company developing novel bispecific antibody products to improve the treatment of cancer.

Skolska 88 99109 Slovakia

Koreničova 1 Bratislava, 811 03 Slovak RepublicThe company’s research and production divisions focus in particular on the synthesis of benzothiazoles, benzimidazoles, furanes, indoles, isocyanates, isothiocyanates, thiophene derivatives, phosphorus compounds, pyridines, and rare sugars capable of providing these synthetic products from a few grams to many kilograms.

2101/9 Radlinského Bratislava, Bratislavský, 811 07 SlovakiaThe company’s research and production divisions focus in particular on the synthesis of benzothiazoles, benzimidazoles, furanes, indoles, isocyanates, isothiocyanates, thiophene derivatives, phosphorus compounds, pyridines, and rare sugars capable of providing these synthetic products from a few grams to many kilograms.

Breitenfurter Strasse 251 A-1230 Wien AustriaGlobopharm offers development and manufacturing of pharmaceutical products.

Bratislava, Slovak RepublicGoodwill Research provides clinical trial management, sample quantification, analytical reports, and internal medicine.

Modra, SlovakiaHameln provides custom development, biological studies, clinical trials, and GLP services

Horizon Genomics GmbH Campus-Vienna-Biocenter 5 1030 Wien Austria‎Built upon decades of experience engineering cell lines, RNA synthesis, and bioinformatic design, we have created a unique portfolio of reagents and services that empower researchers to push their work forward with data generated from cell models. Horizon is leveraging its technological expertise to provide cell engineering tools and services to its customers in three key areas of the therapeutic ecosystem: basic research, drug discovery and development and therapeutic applications. Some of our central services include: • Screening & Cell line engineering services: tools and services that are designed to improve the outcome of drug discovery and development • BioProduction cell lines: engineered CHO cell lines that are designed to enable efficient biologics manufacturing Horizon’s customers include biopharmaceutical and diagnostics companies, contract research and manufacturing organizations and academic researchers across the globe. Horizon sells its tools and services to more than 2,000 unique customers in over 60 countries, including to 19 of the 20 largest biopharmaceutical companies by revenue. On the contract research front, Horizon’s service group supports researchers with cell line engineering, functional genomic screening, high-throughput immuno-oncology assays, compound profiling, drug combination screening, using CRISPR, or siRNA for a variety of cell-based assays. Horizon is now part of Revvity. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

94-96 Handelskai Wien, Wien, 1200 AustriaIllumina offers next generation sequencing and genotyping services.

Am Campus 1, 3400 Klosterneuburg, AustriaThe Institute of Science and Technology Austria (IST Austria) is a young international institute dedicated to basic research and graduate education in the natural and mathematical sciences, located in Klosterneuburg on the outskirts of Vienna. Established jointly by the federal government of Austria and the provincial government of Lower Austria, the Institute was inaugurated in 2009 and will grow to about 90 research groups by 2026. The governance and management structures of IST Austria guarantee its independence and freedom from political and commercial influences. The Institute is headed by the President, who is appointed by the Board of Trustees and advised by the Scientific Board. The first President of IST Austria is Thomas A. Henzinger, a leading computer scientist and former professor of the University of California at Berkeley and the EPFL Lausanne in Switzerland.

Clemens Maria Hofbauer-G. 6 A-2344 Maria Enzersdorf Austria, EuropeInte:Ligand offers pharmacore development and modeling, lead structure optimization, virtual compound library generation, and virtual screening services.

Haus der Forschung Sensengasse 1 A-1090 Wien, AustriaJOANNEUM RESEARCH is a publicly owned research organisation located in Graz, Austria. Its Institute HEALTH is committed to research in the medical field and health-related disciplines, positioned at the crossroads of technology and medicine. Our clients are mainly pharmaceutical companies (R&D, early development, translational, manufacturing), biotech and medical device companies. To meet industry needs and standards we are certified according to Good Laboratory Practice and EN ISO 13485. Area(s) of expertise 1) Preclinical and clinical studies to investigate local PK, PD profiles in brain, dermal and adipose tissue We carry out ex-vivo and in-vivo studies to investigate the permeation, stability and pharmacokinetics/pharmacodynamics (PK/PD) of active pharmaceutical ingredients under development. OFM studies in live animals with active blood and lymphatic circulation provide important information such as the distinction between permeation and clearance kinetics. The unique capability of OFM technology enables the study of large molecules and immune cells for a better understanding of the mechanism of action (MOA) of the drug candidate under investigation. As a result, the in vivo OFM approach has proven its value in predicting clinical efficacy and supports the right development decisions before entering the clinical phase. ==> https://openflowmicroperfusion.com/ 2) Bioequivalence testing for topical generics: learn more Currently, FDA approval for topical generic drugs requires a clinical endpoint study to show bioequivalence (BE). Standard blood PK studies are not useful for BE tests of topical dermal generics. dOFM allows a PK based BE approach directly in the skin. ==> https://croservices.joanneum.at/ 3) Bioanalysis (under GLP/non-GLP) We analyze low volume samples from all biological matrices to determine PK/PD profiles and to support your biomarker research. We are experts in mass spectrometry and immuno-chemistry and we are dedicated to develop analytical methods for challenging analytes on GLP/GCLP standard, e.g. with ultra-high sensitivity and high sample throughput. ==> https://croservices.joanneum.at/ 4) Pharmaceutical analysis (under GLP/non-GLP) We develop customized solutions for our customers in the pharmaceutical industry in the areas of cleaning validation, content determination and impurity testing. To meet your requirements we combine highly specialized analytics and certified quality standards with know-how from research and development. ==> https://croservices.joanneum.at/ 5) Targeted and untargeted Metabolomics: We are actively developing innovative and optimized analytical methods that can be used to investigate metabolic processes. Toward this end, we pool our bio-analytical, statistical, medical, biological and biochemical expertise and conjoin it with advanced information technology. This strategy allows us to offer a wide range of customer-oriented services in the field of metabolomics and metabolic research. ==> https://croservices.joanneum.at/ 6) Data Management for clinical studies: We provide GCP-compliant comprehensive data management services specifically tailored to your clinical and preclinical studies. We manage data from various sources (e.g. clinical data, laboratory data, medical device data) and provide an easy-to-use, fully validated Electronic Data Capture (EDC) system for your clinical data. We assist with all your data management tasks in a clinical trial, from protocol development to study reporting. ==> https://croservices.joanneum.at/ 7) Biostatistics for clinical studies We offer a wide range of specialized biostatistical services to manage all aspects of your study from design to data analysis. We help you design and power your study to become statistically meaningful and cost-effective. Our profound understanding of clinical trials and our advanced statistical methodology ensures results that are scientifically accurate, validated and reproducible. ==> https://croservices.joanneum.at/ 8) Development of Clinical Decision Support systems We develop and study intelligent software systems to provide safe and evidence-based support for complex clinical processes. We aim to enable professional medical decision-making and adequate patient care by providing modern ICT solutions directly at the point of care.

5 Campus-Vienna-Biocenter Campus Vienna Biocenter 5 Wien, Wien, 1030 AustriaLexogen develops innovative technologies such as 3’ mRNA-Seq, which have been widely adopted by thousands of scientists worldwide. In addition, we offer end-to-end solutions for RNA analysis and NGS sequencing. Lexogen provides fully customizable NGS Services, which include everything from experimental design to bioinformatics.

Wienerbergstrasse 11 Vienna Twin Tower A-1100 Wien AustriaLipomed provides reference standards and pharmaceuticals for the treatment of rare diseases.

73 Mlynske NIvy Bratislava, 821 05 Slovakia

Dr. Bohr-Gasse 9Max F. Perutz Laboratories at the Campus Vienna Biocenter offers its facilities to support research in cell signaling, infection biology, RNA biology, computational biology, and structural biology.

Vienna, Vienna AustriaMax F. Perutz Laboratories at the Campus Vienna Biocenter offers its facilities to support research in cell signaling, infection biology, RNA biology, computational biology, and structural biology.

23 Spitalgasse Wien, Wien, 1090 AustriaFlow cytometry has become an essential and widespread resource for the study of biological material.

23 Spitalgasse Wien, Wien, 1090 AustriaThe Core Facility Imaging is located in the Anna Spiegel Building – Center of Translational Research. In the area of Imaging a large variety of techniques is available to address complex problems in vitro, in situ and in vivo.

23 Spitalgasse Wien, Wien, 1090 AustriaThe Core Facilities for Genomics, Proteomics, Flow Cytometry and Imaging at the Medical University of Vienna provide scientists with easy access to state-of-the-art high-end equipment and cutting edge technology to address highly sophisticated research questions.

23 Spitalgasse Wien, Wien, 1090 AustriaThe Core Facility Genomics is a service unit for the characterization of genetic causes of widely-spread diseases by means of high-throughput analyses.

Valtická 337, 691 44 Lednice, Česká republika

Leberstrasse 20 Vienna, 1110 AustriaMicrosynth (founded in 1989) is a European leading company in the area of DNA/RNA synthesis & analysis. The main activities are divided into following three business areas: 1. DNA/RNA SYNTHESIS DNA/RNA oligos & probes for R&D Antisense oligos (e.g. 2'-MOE or LNA-gapmers) for drug discovery DNA oligos for diagnostic applications Pilot scale synthesis (gram quantities) 2. DNA/RNA Analysis and Sequencing Sanger sequencing (incl. GMP sequencing) NGS sequencing (16S/ITS, RNA-Seq, etc.) PCR & qPCR & digital PCR Genotyping (GBS, cell lines, fragment analysis) DNA/RNA isolation 3. Contract Research/Outsourcing Assay development (e.g. IVD, liquid biopsy, etc.) Assay validation (e.g. validation of assays according to ICH guidelines) Biological tests (e.g. batch and release tests for drugs) Gene editing/gene therapy (e.g. CRISPR editing analysis, rAAV characterization) At its headquarter in Balgach close to St. Gallen Microsynth employs a staff of about 60 people. Microsynth has subsidiaries in Austria (Microsynth Austria GmbH) and Germany (Seqlab GmbH).

Vienna, AustriaThe Medical University of Vienna Biobank is an interface between basic and clinical research with the aim of exploring new diagnostic, prognostic, predictive biomarkers, risk markers and therapeutic strategies to allow, and to deepen the understanding of disease etiology and pathogenesis. As a service center at the Medical University of Vienna sees itself with the principles of ""Good Scientific Practice"" and academia committed. Aware that excellence can be achieved in clinical research only with appropriate ethical standards, the information or consent is subject prerequisite for inclusion in a project of the Medical University of Vienna Biobank. In addition, this also means a responsible use of the provided biological material and the privacy of the subjects involved.

BioTech Center Muthgasse Muthgasse 11/2 Vienna, 1190 AustriaMycoplasma Biosafety Services GmbH - Driving Innovation in Mycoplasma Detection, Prevention & Control Mycoplasma Biosafety is the global technological and scientific innovation leader in mycoplasma detection, prevention and control. We offer the most comprehensive range of mycoplasma tests by the compendial culture methods and new rapid NAT-based assays, including culture media and reference standard products for mycoplasma testing, test and process validations.

Veterinärplatz 1Mycosafe Diagnostics provides mycoplasma testing, identification, consulting, and validation studies.

Am Kanal 27 Vienna Vienna, Austria, 1110 AustriaNext-generation CRISPR screens - a powerful technology to advance drug target identification and validation At Myllia, we utilize the CROP-Seq (for “CRISPR Droplet Sequencing”) workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next generation CRISPR screens. Our powerful approach has broad applications in identifying novel drug targets, elucidating unknown mechanisms of actions of drugs and understanding genetic variants linked to disease risk. We partner with biotech and pharma companies across the globe, and we perform high-throughput CRISPR screens in cancer cells or primary human T cells on a fee-for-service basis. All CRISPR screens using CRISPR KO, CRISPR interference or CRISPR activation workflows are specifically customized to the needs of our clients and we offer various read-outs (incl. fitness, FACS, flow cytometry, CITE-seq and single-cell transcriptomics) as well as computational biology analysis of NGS data. Finally, we cover end-to-end workflows from initial project design to wet-lab screening and the analysis of NGS data that is fully owned by our clients (no royalties, no strings attached). Contact: Website: www.myllia.com Email: info@myllia.com Accounts managing Myllia's Scientist.com profile: Dr. Thomas Moser (t.moser@myllia.com) Dr. Henrik Schmidt (h.schmidt@myllia.com)

Christine-Touaillon -Straße 11/2.12 Wien, Wien, 1220 AustriaGMP-grade gene synthesis at record speed – even for AAV & complex sequences.

11 Christine-Touaillon-Straße Wien, Wien, 1220 AustriaGMP-grade gene synthesis at record speed – even for AAV & complex sequences.

Vienna, Vienna AustriaNBS-C BioScience offers assay development for target identification and validation in addition to SPR and ELISA services.

Brunnerstrasse 69 Objekt 3 Vienna, A-1230 AustriaNBS-C BioScience offers assay development for target identification and validation in addition to SPR and ELISA services.

Strecnianská 13, 851 05 Bratislava, SlovakiaNeox is a privately owned full services clinical CRO. We conduct clinical trials for pharmaceutical, biotechnology, medical device companies and other CRO’s throughout Europe and US. Our services are offered for Phase I-IV. DRUG DEVELOPMENT - Medical Writing, Site Contracting, Clinical Monitoring, Project Management, Pharmacovigilance, Regulatory, Medical Monitoring, Outsourcing. MEDICAL DEVICE DEVELOPMENT PHARMACOVIGILANCE & REGULATORY REAL WORLD EVIDENCE/DATA & HEOR DATA MANAGEMENT & BIOSTATISTICS We offer our services as a full service package or individually as a tailored solution to your specific needs. Years of clinical research experience, understanding local requirements and established relationships with investigators ensures that your trial will always be performed in an optimal setting for high patient enrollment. Neox offices: Czechia, California, Germany, Poland, Hungary, Bulgaria, Slovakia, Romania. Neox also operates in: Austria, Belgium, Estonia, France, Finland, Italy, Latvia, Lithuania, Netherlands, Spain, United Kingdom and others.

Garnisongasse 11 Top 7, 3rd floor Vienna, 1090 AustriaA single-person company according to Austrian legal law

Oberlaaerstrasse 235 Vienna, Vienna, 1100 AustriaOctapharma develops and produces medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centers and other external sources.

98 Pötzleinsdorfer Straße 1/4 Wien, Wien, 1180 AustriaOleksandr Petrenko, MD. Physician - scientist with a background in computational systems biology, currently working as an independent consultant and contract scientist.

Helmut‐Qualtinger Gasse 6, VBC 5 Vienna, 1030 AustriaOpGen is focused on delivering innovative solutions to rapid molecular detection of severe infectious diseases that help guide clinicians with actionable information about life threatening infections to improve patient outcomes and support infection prevention and control and antibiotic stewardship. As part of its genomics offering, ARES isolate sequencing service (ARESiss) is available through the OpGen lab in Rockville, Maryland, USA and the ARES lab in Vienna, Austria. In addition, ARES offers a 16S/ITS amplicon metagenomic sequencing solution (ARESid) for pathogen identification and a culture-free universal pathogenome assay (ARESupa) for comprehensive AMR marker screening of native patient and environmental samples. Sequence characterization supports outbreak analysis, surveillance, and infection prevention and control. To enable labs globally with bioinformatics tools to analyze microbial genomes, OpGen offers AREScloud, a user-friendly web application for AMR surveillance and outbreak analysis, powered by ARESdb. ARESdb is a proprietary AMR reference database comprised of microbial sequences with annotated AMR biomarkers that cover resistance genes and mutations, and it includes matching phenotypic AST data. This enables the AI-powered prediction of phenotypic resistance (predictive AST) directly from genome data.

Hasengasse 9/37 Vienna, 1100 AustriaA Science Art Freelance Business

Donaustrasse 99, 3400 Klosterneuburg, AustriaPolymun Scientific offers services in contract development biopharmaceuticals, contract manufacturing biopharmaceuticals, liposomal formulation of drugs and further services.

Donaustraße Klosterneuburg, 3400 AustriaPolymun Scientific offers services in contract development biopharmaceuticals, contract manufacturing biopharmaceuticals, liposomal formulation of drugs and further services.

99 Donaustraße Klosterneuburg, Niederösterreich, 3400 AustriaPolymun was founded in 1992 by Prof. Hermann Katinger. It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. These revenues are invested in the proprietary product pipeline and the further development of technology platforms. The R&D projects and technologies are open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals (§63 Austrian Pharmaceutical Law) thus meeting the EU requirements for drug manufacturing. The last inspection by the Austrian regulatory authority AGES on behalf of EMA has taken place in June 2015, the last inspection by FDA in October 2013. COMPETENCE & SERVICES The two core competences of Polymun are the development and manufacture of biopharmaceuticals using mammalian cell technology as well as Polymun's innovative liposome technology and expertise. Today, Polymun can apply this drug delivery platform to all kinds of pharmaceutically active ingredients. The industrial applicability in scale and price is a common focus throughout all projects and technologies.

Dérera 7At PRA Health Sciences, providing innovative solutions for our clients is what we do. But innovation just for the sake of innovation isn’t why we do it. Side-by-side with our clients, we strive to move drug discovery forward, to help them develop life-saving and life- improving drugs. We help change people’s lives for the better every single day. It’s who we are. Innovating to help people is at the heart of our process, but it’s even more than that. It’s also our privilege.

Udernicka 5Premier Research, a midsize clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.

University of Natural Resources and Applied Life Sciences, Vienna (BOKU)ProGlycAn offers glycan analysis, protein analysis, protein sequencing, and amino acid analysis services.

55 Theodor Kery-Straße Neutal, Burgenland, 7343 AustriaQBDC CMC consulting company that is offering tools to solve common problems in the development of biologics. EDDI, the Epigenetic Digital Data Interface, revolutionizes bioprocess development by providing real-time insights into cellular behavior. Traditionally, bioprocess optimization has relied on comparing inputs and outputs without fully understanding the underlying cellular mechanisms. EDDI, developed by QBDC, bridges this gap by "listening" to cells and translating their signals into actionable digital data. By monitoring cellular responses to changes in their environment, EDDI enables precise nutrient delivery, optimizing bioprocesses for faster development, higher productivity and robustness.

2 Helmut-Qualtinger-Gasse Wien, Wien, 1030 AustriaQUANTRO combines and exploits innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.

Doktor-Bohr -Gasse Wien, Wien, 1030 AustriaQUANTRO combines and exploits innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.

Vienna, Vienna AustriaResearch Institute of Molecular Pathology focuses on research in the fields of molecular biology, cellular biology, circuit neuroscience, and diseases.

Dr. Bohr-Gasse 7Research Institute of Molecular Pathology focuses on research in the fields of molecular biology, cellular biology, circuit neuroscience, and diseases.

Campus-Vienna-Biocenter 1 Vienna, 1030 AustriaThe Research Institute of Molecular Pathology (IMP) is a leading basic research institute. Its 15 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP is the ideal environment for curiosity-driven biomedical research. As part of the Vienna Biocenter (VBC), the IMP is embedded in one of Europe’s biggest life science hubs with 1400 researchers. Since the IMP’s establishment in 1985, scientists at the institute are addressing important problems in research areas including molecular and cellular biology; structural biology and biochemistry; gene expression and chromosome biology; stem cell biology and development; immunology and cancer; and neuroscience. In pursuit of their research goals, scientists at the IMP employ the latest methods and equipment in molecular genetics, imaging, biochemistry and structural biology on an array of model systems. This is achieved with the help of state-of-the-art core facilities that are available to all research groups free of charge. Research at the IMP is supported by an annual budget of approximately 28 million Euros.

Brehmstrasse 14 Vienna, 1110 AustriaWe are synthetic DNA company that specializes in hard-to-make DNA. Please provide sequences for quoting.

Bremstrasse 14 Wein, Vienna, 1100 AustriaWe are synthetic DNA company that specializes in hard-to-make DNA. Please provide sequences for quoting.

Boltzmanngasse 11 A-1090 Vienna AustriaSANOCHEMIA offers development and manufacture of novel drugs and diagnostics in; neurodegeneration, pain, oncology and diagnostics based on contrast media.

29 Zoldfasi roadSeqOmics provides genomic and bioinformatic services.

Laaer Strasse 7-9Shimadzu offers analytical technology, laboratory instruments, testing machines, and scales.

Schlosshofer Strasse 11, 3. Floor Vienna, A-1210 AustriaThe Siesta Group is a comprehensive service provider supporting the measurement of sleep, wakefulness and brain activity in clinical trials and research. This encompasses, among others, high quality services concerning polysomnography (PSG), pharmaco-electroencephalography (pharmaco-EEG) and event-related potentials (ERP).

Tullnerbachstr. 61 - 65 3011 Neupurkersdorf / Austria

Ilkovicova 6 Bratislava, Slovakia, 84215 SlovakiaSynkola is a well-adapted CRO in the field of organic synthesis. We are located in campus of Comenius University in Bratislava capital of Slovak Republic member state of European Union. We have six fully equipped chemical laboratories and some representation rooms. Our laboratories have been renewed few years ago, including installing new fume hoods. Each laboratory is equipped with MPLC and air-condition and other unique laboratory technic (HPLC, Advion Compact MS, TLC Plate Express for MS, Par autoclave, prepHPLC etc.). With the Synkola services order, you will receive our motivated chemists skills to perform research from beginning to the end. Our chemists are fully developed to be independent in each projects and give a fast feedback to project sponsor if any issues come up during solving the project. We have know-how to handle various heterocyclic compounds, perform purification of compounds which are difficult to separate/purify. Process development of problematic synthetic routes from mgs to hundreds of grams. To decrease the synthesis costs we exclude FLC in higher scale ups by using methods like crystallization, distillation, sublimation and others. Our next skill is that we do optimization of HPLC methods for a new class of compounds. If requested, we do final metal scavenging processes to get ultra-pure sample. We have experiences with chiral compounds synthesis, palladium catalyzed reactions, organometallic chemistry and preparation of deuterium enriched targets. We are experts in sealed tube reactors, work under strictly water, oxygen, light free conditions. The Parr autoclave allow us to perform special reactions like carbonylations, hydrogenations.

1 Mlynská dolina 841 04 SlovakiaSYNKOLA, Ltd. was founded on the 1st January 1991 in Bratislava by three partners. They have long-time and international experience in the area of organic substance synthesis and especially in the area of biologically active substances and chemical specialties. They are authors of more than 200 scientific publications and more than 150 patents; many of them have been realized in technical praxis. Nowadays, the organization employs 14 top chemists with Ph.D. qualification, who have graduated post-doctoral and other fellowships at prominent foreign universities and institutes – especially in Switzerland (ETH Zurich), in the USA, France, Canada, Sweden, etc. SYNKOLA is located in Comenius University campus and takes advantages of following analytic equipment GC-MS, LC-MS, 300MHz NMR, FT-IR. Laboratories are equipped with Parr autoclave and all other necessary equipment for each kind of organic synthesis. There are available also equipments with microwave radiation. profile

Mlynská dolina 1, 84215 Bratislava, 841 04, SlovakiaSYNKOLA, Ltd. was founded on the 1st January 1991 in Bratislava by three partners. They have long-time and international experience in the area of organic substance synthesis and especially in the area of biologically active substances and chemical specialties. They are authors of more than 200 scientific publications and more than 150 patents; many of them have been realized in technical praxis. Nowadays, the organization employs 14 top chemists with Ph.D. qualification, who have graduated post-doctoral and other fellowships at prominent foreign universities and institutes – especially in Switzerland (ETH Zurich), in the USA, France, Canada, Sweden, etc. SYNKOLA is located in Comenius University campus and takes advantages of following analytic equipment GC-MS, LC-MS, 300MHz NMR, FT-IR. Laboratories are equipped with Parr autoclave and all other necessary equipment for each kind of organic synthesis. There are available also equipments with microwave radiation. profile

Quellenstrasse 110 Wien, Wien, 1100 AustriaWe are one of the leading Austrian trade and service partners for medical and laboratory products.Today we distribute and maintain consumables, research products, laboratory instruments and specific diagnostic products. Currently, we can offer a range of more than 2.6 million products and numerous services. Our strength lies in 60 years of experience in the Austrian Life Science Marketplace.

Quellenstrasse 110 Wien 10., Favoriten, Wien, 1100 AustriaWe are one of the leading Austrian trade and service partners for medical and laboratory products.Today we distribute and maintain consumables, research products, laboratory instruments and specific diagnostic products. Currently, we can offer a range of more than 2.6 million products and numerous services. Our strength lies in 60 years of experience in the Austrian Life Science Marketplace.

Leberstrasse 20 Vienna, Vienna, 1110 AustriaTAmiRNA is a Viennese Biotech company, which was founded in 2013. TAmiRNA is dedicated to identifying and validating microRNA biomarkers that can be used for drug development, early diagnosis, and prognosis of disease, and as companion diagnostic tests to support treatment decisions. This work requires high-level expertise in working with miRNAs, requiring sophisticated techniques and tools to screen microRNA transcript levels in virtually any type of cell tissue or biological sample. TAmiRNA has a successful track record and impressive pipeline in developing novel miRNA biomarkers for toxicology studies and as predictors of ailments, using these to develop companion diagnostics and monitor disease progression. As a CRO TAmiRNA is able to offer a wide range of validated, high-quality microRNA services, providing specific solutions for: • Transcriptomics: RNASeq, small RNA-Seq, and qPCR analysis of biofluids, cells, tissues, and extracellular vesicles (EVs) to discover and validate multivariate miRNA, non-coding RNA, and messenger RNA biomarkers. • Spatial omics: coupling of laser-assisted microdissection of complex tissues and RNA-seq to decipher gene expression in complex tissues in-situ. • Customer-tailored microRNA biomarker discovery and validation using proprietary small RNA-Seq normalization strategies, machine learning, and customized protocols • Extracellular vesicles, exosomes, nanovesicles: Proteomic, Lipidomic, and Transcriptomic analysis. Characterization of EVs according to the guidelines of the International Society for Extracellular Vesicles. • toxomiR: a microRNA-based screening assay for organ injury in 9 different organ systems, utilizing serum or plasma samples • hepatomiR: a CE-certified assay for the quantification of liver biomarkers (miR-122, miR-192, miR-151a) in human plasma for diagnosis of chronic or acute liver injury.

Nobelova 34 (located in ISTROCHEM area) P.O. BOX 29 836 05 Bratislava SlovakiaTAU-CHEM, Ltd. - development, research and fine chemicals manufacturing company established in 1994 by the partners with extensive experience in organic synthesis and technology The company specializes in the heterocyclic chemistry, as well as in the more conventional fields of organic synthesis The company´s competency in process development and scale up contributes to raise the production innovation. Mission TAU-CHEM principal function is to carry out a successful market-oriented exploitation by bridging the gap between academic research and large scale realization - technology development or industrial up scaling. The TAU-CHEM ´s business model derived from its mission is based on transferring academic scale chemistry (mg) to production quantities (kg) process optimization followed by transfer to full production (tones).

2 Sellnergasse Bad Vöslau, Niederösterreich, 2540 AustriaFounded in 1992 by Hermann Koroschetz, TB Agrartechnik today has a staff of seven employees with extensive and well-founded know-how, obtained among others by university degrees in agriculture, biology and biotechnology. Anita Olson, the current managing director, joined the company as a partner in 1994 and has long term and well-founded experience in plant protection and biocidal products. The company is based in Bad Vöslau, a small town situated in one of the most intensively utilised agricultural regions of Austria. TB Agrartechnik also is a testing facility officially recognised by the Austrian Ministry of Agriculture and Forestry in accordance with the Austrian plant protection product law respectively directive 91/414/EEC (93/71/EEC). The results of efficacy testing can additionally be used as a support in the registration of the tested product within the European Community. TB Agrartechnik is specialised in the implementation and handling of the registration of plant protection products, biocidal products and other chemicals.

Brunner Str 67 Vienna, 1230 AustriaTechnoclone offers reagents for diagnostic analysis including plasma, inhibitors, proteins and chromogenic reagents.

Brunnerstrasse 67 Vienna, 1140 AustriaTechnoclone Herstellung von Diagnostika und Arzneimitteln GmbH was founded in 1987 by Prof. Dr. Bernd R. Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibind) in the field of fibrinolysis. From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an distribution system all over the world. Production and OEM Products Technoclone is a world-leading producer of diagnostics tests, equipments and research products in the area of blood clotting. It offers both global as well as speciality coagulation tests. We see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). With the development of the new high power LED quenching module the Ceveron s100 is a milestone in speciality haemostasis diagnostics. Technoclone´s high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies. Research & Development The focus of Technoclone´s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone´s own research division and in close cooperation with Universities and international and national research consortia. Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases Technoclone, on the forefront of diagnostic challenges of tomorrow.

Brunnerstrasse 67 Vienna, Vienna, 1140 AustriaTechnoclone Herstellung von Diagnostika und Arzneimitteln GmbH was founded in 1987 by Prof. Dr. Bernd R. Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibind) in the field of fibrinolysis. From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an distribution system all over the world. Production and OEM Products Technoclone is a world-leading producer of diagnostics tests, equipments and research products in the area of blood clotting. It offers both global as well as speciality coagulation tests. We see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). With the development of the new high power LED quenching module the Ceveron s100 is a milestone in speciality haemostasis diagnostics. Technoclone´s high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies. Research & Development The focus of Technoclone´s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone´s own research division and in close cooperation with Universities and international and national research consortia. Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases Technoclone, on the forefront of diagnostic challenges of tomorrow.

1 Universitätsring Wien, Wien, 1010 AustriaKnowledge of structure is basic biological research.

Brunner Strasse 69 Objekt 3 Wien, Vienna, 1230 AustriaVela Laboratories is a world-wide acting, GLP & GMP-certified, GCLP-compliant accredited contract laboratory. Our services cover analytical services for Biologics (ATMPs, Biopharmaceuticals, Originator products, Biosimilar Candidates, Biosimilars, Blood and blood components, Vaccines), Chemicals and Excipients from early stages of product development (non-clinical, clinical) until market release testing for Pharma and Biotech companies as well as storage facilities enabling long term stability studies and all types of microbiological services. VelaLabs is a member of Tentamus group.

Dr. Bohr Gasse 3 1030 Vienna, AustriaThe Vienna Biocenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter. VBCF was founded in 2010 as a limited liability company (GmbH) according to Austrian law. VBCF’s stakeholders are: Campus Vienna Biocenter Association (50%) Max F. Perutz Laboratories GmbH (25%) IMBA – Institute of Molecular Biotechnology (15%) GMI – Gregor Mendel Institute of Molecular Plant Biology (10%) The operation of VBCF is funded by the Federal Ministry of Science, Research and Economy (bm.wfw) and the City of Vienna, by fees charged for delivered services and by additional research grants. VBCF operates 11 scientific core facilities and the shared Child Care Center of the Vienna Biocenter as shown in the organization chart below.

3 Doktor-Bohr-Gasse Wien, Wien, 1030 AustriaThe Vienna Biocenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter. VBCF was founded in 2010 as a limited liability company (GmbH) according to Austrian law. VBCF’s stakeholders are: Campus Vienna Biocenter Association (50%) Max F. Perutz Laboratories GmbH (25%) IMBA – Institute of Molecular Biotechnology (15%) GMI – Gregor Mendel Institute of Molecular Plant Biology (10%) The operation of VBCF is funded by the Federal Ministry of Science, Research and Economy (bm.wfw) and the City of Vienna, by fees charged for delivered services and by additional research grants. VBCF operates 11 scientific core facilities and the shared Child Care Center of the Vienna Biocenter as shown in the organization chart below.

Donau City Strasse 1ViruSure offers virus validation, prion clearance studies, biodistribution, and biosafety testing services.

Zimmermannplatz 10 Vienna, 1090 AustriaSt. Anna Children’s Cancer Research Institute (CCRI) strives to improve treatment for children and adolescents with cancer by bringing together translational and clinical research with open-minded exploration of basic disease mechanisms. ZANDR was established at the Children´s Cancer Research Institute (CCRI) and is a unique platform to phenotypically screen small compounds on zebrafish models of human diseases. Zebrafish and in particular zebrafish larvae is a well suited vertebrate model system to investigate various human diseases and to perform cost-effective screens for small molecules with therapeutic potential. Funded by FFG, we have established a zebrafish-optimized and automated screening platform, which is open to the scientific community.